Complication rates of ultrasound-guided prostate biopsy: A nation-wide survey in Japan

International Journal of Urology

Volumn 15, Issue 4, 2008, Pages 319-321

  Kakehi, Yoshiyuki ^a   Naito, Seiji ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Complication; Needle biopsy; Prostate; Prostate cancer; Ultrasonography

Indexed keywords

ADULT; ARTICLE; ECHOGRAPHY; FEVER; HEALTH SURVEY; HEMATURIA; HEMOSPERMIA; HOSPITALIZATION; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MORBIDITY; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; RECTUM HEMORRHAGE; SEPSIS; URINE RETENTION;

BIOPSY; HUMANS; JAPAN; MALE; PROSTATE; RETROSPECTIVE STUDIES;

EID: 41749106659     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02048.x     Document Type: Article

References (21)

1. Okihara K, Kitamura K, Okada K et al. Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan. Int. J. Urol. 2008 15:156 60.
2. Matsumoto K, Satoh T, Egawa S et al. Efficacy and morbidity of transrectal ultrasound-guided 12-core biopsy for detection of prostate cancer in Japanese men. Int. J. Urol. 2005 12:353 60.
3. Chiang IN, Chang SJ, Pu YS et al. Major complication and associated risk factors of transrectal ultrasound guided prostate needle biopsy: a retrospective study of 1875 cases in Taiwan. J. Formos. Med. Assoc. 2007 106:929 34.
4. Sieber PR, Rommel FM, Theodoran CG et al. Contemporary prostate biopsy complication rates in community-based urology practice. Urology 2007 70:498 500.
5. Lee G, Attar K, Laniado M, Karim O. Safety and detailed patterns of morbidity of transrectal ultrasound guided needle biopsy of prostate in a urologist-led unit. Int. Urol. Nephrol. 2006 38:281 5.
6. Sheikh M, Hussein AYT, Kehinde EO et al. Patients' tolerance and early complications of transrectal sonographically guided prostate biopsy: prospective study of 300 patients. J. Clin. Ultrasound 2005 33:452 6.
7. Berger AP, Gozzi C, Steiner H et al. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10, and 15 Cores. J. Urol. 2004 171:1478 81.
8. Ghani KR, Dundas D, Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol. BJU Int. 2004 94:1014 19.
9. Alecsandru D, Gestoso I, Romero A et al. E. coli multiresistant meningitis after transrectal prostate biopsy. Sci. World J. 2006 6:2323 6.
10. Hoshi A, Nitta M, Hongoh S et al. Sepsis following transrectal prostate biopsy: a report of 2 cases and reviewed similar cases in Japan. Hinyokika Kiyo 2006 52:645 9.
11. Manoharan M, Ayyathurai R, Nieder AM, Soloway MS. Hemospermia following ultrasound-guided prostate biopsy: a prospective study. Prostate Cancer Prostatic Dis. 2007 10:283 7.
12. Saito S. Prostate-specific antigen cut-off point of 2.5 ng/mL and increasing the number of prostate biopsies results in the detection of curable prostate cancer even in Japanese population. Int. J. Urol. 2007 14:709 12.
13. Argyropoulos AN, Doumas K, Farmakis A et al. Time of administration of a single dose of oral levofloxacin and its effect in infectious complications from transrectal biopsy Int. Urol. Nephrol. 2007 39:897 903.
14. Nobrega de Jesus CM, Correa LA, Padovani CR. Complications and risk factors in transrectal ultrasound-guided prostate biopsies. Sao Paulo Med. J. 2006 124:198 202.
15. Paul R, Schöler S, van Randenborgh H et al. Morbidity of prostatic biopsy for different biopsy strategies: is there a relation to core number and sampling region? Eur. Urol. 2004 45:450 56.
16. Kawakami S, Yamamoto S, Numao N et al. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Int. J. Urol. 2007 14:719 24.
17. Miller J, Perumalla C, Heap G. Complications of transrectal verwsus transperineal prostate biopsy. ANZ J. Surg. 2005 75:48 50.
18. Schaeffer AJ, Montorsi F, Scattoni V et al. Comprison of a 3-day with 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate. BJU Int. 2007 100:51 7.
19. Matsumoto T, Kiyota H, Matsukawa M et al. Japanese guidelines for prevention of perioperative infections in urological field. Int. J. Urol. 2007 14:890 909.
20. Ishihara M, Suzuki H, Akakura K et al. Baseline health-related quality of life in the management of prostate cancer. Int. J. Urol. 2006 13:920 25.
21. Carisson S, Aus G, Wessman C et al. Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomized study. Eur J. Cancer 2007 43:2109 16.